PATENT CLAIM ANALYSIS

Application Number: 16076387
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "222500"]

Abstract:
A series of 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted in the 5-position by a phenyl moiety NH which in turn is meta-substituted by an optionally substituted fused bicyclic heteroaromatic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.

Claim (Index 13):
A method for the treatment and/or prevention of malaria, which comprises administering to a patient in need of such treatment an effective amount of a compound of formula (I) as defined in  claim 1  or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.21154
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13508964', '15039092', '15513357', '15102003', '14357340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957580802854833
- 35 USC 102 Novelty (BERT): 0.5177663507611115
- Combined Prediction Score: 0.7679589073330462
- Mean Citation Score: 291.006704
- Max Citation Score: 306.5469700000001
- Similarity Product: 221.2245738551933

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test